Interruption of Biologic Therapy JCG0030 v4.1
A clinical guideline for Interruption of Biologic Therapies for Elective Surgery in Adults and Children with Rheumatoid Arthritis JIA and Ankylosing Spondylitis.
Patients are educated about pausing biologic therapy dosing prior to surgery.
Staff involved in preparing patients for elective surgery need to be aware of the rationale for this pause and details of the specific time scales
Clinical GuidelinesThis guideline has been approved by the Trust's Clinical Guidelines Assessment Panel as an aid to the diagnosis and management of relevant patients and clinical circumstances. Not every patient or situation fits neatly into a standard guideline scenario and the guideline must be interpreted and applied in practice in the light of prevailing clinical circumstances, the diagnostic and treatment options available and the professional judgement, knowledge and expertise of relevant clinicians. It is advised that the rationale for any departure from relevant guidance should be documented in the patient's case notes.
The Trust's guidelines are made publicly available as part of the collective endeavour to continuously improve the quality of healthcare through sharing medical experience and knowledge. The Trust accepts no responsibility for any misunderstanding or misapplication of this document.